Reveromycins, new inhibitors of eukaryotic cell growth. II. Biological activities.

DOI PubMed 被引用文献10件 オープンアクセス
  • TAKAHASHI HIDETOSHI
    Research Institute of Life Science, Snow Brand Milk Products Co., Ltd.
  • OSADA HIROYUKI
    Antibiotics Laboratory, RIKEN, The Institute of Physical and Chemical Research
  • KOSHINO HIROYUKI
    Antibiotics Laboratory, RIKEN, The Institute of Physical and Chemical Research
  • SASAKI MUTSUMI
    Antibiotics Laboratory, RIKEN, The Institute of Physical and Chemical Research
  • ONOSE RIE
    Antibiotics Laboratory, RIKEN, The Institute of Physical and Chemical Research
  • NAKAKOSHI MASAMICHI
    Research Institute of Life Science, Snow Brand Milk Products Co., Ltd.
  • YOSHIHAMA MAKOTO
    Research Institute of Life Science, Snow Brand Milk Products Co., Ltd.
  • ISONO KIYOSHI
    Antibiotics Laboratory, RIKEN, The Institute of Physical and Chemical Research Present address: Department of Marine Science, School of Marine Science and Technology, Tokai University

書誌事項

タイトル別名
  • II. BIOLOGICAL ACTIVITIES

この論文をさがす

説明

Reveromycins A, B, C and D showed inhibitory activity against EGF-stimulated mitogen response in Balb/MK cells. Furthermore reveromycins A, C and D exhibited morphological reversion of srcts-NRK cells, antiproliferative activity against human tumor cell lines and antifungal activity. The effects of reveromycins A, C and D on eukaryotic cells were closely similar to each other, but those of reveromycin B were very weak. In vitro studies revealed that reveromycin A is a selective inhibitor of protein synthesis in eukaryotic cells.

収録刊行物

被引用文献 (10)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390001204148546176
  • NII論文ID
    130003502367
  • DOI
    10.7164/antibiotics.45.1414
  • COI
    1:CAS:528:DyaK3sXjsFI%3D
  • ISSN
    18811469
    00218820
    http://id.crossref.org/issn/00218820
  • PubMed
    1429226
  • 本文言語コード
    en
  • 資料種別
    journal article
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
    • OpenAIRE
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ